What is allogeneic cell therapy, and what's driving this market's 25%+ annual global growth?

Phoenix, az / accesswire / august 24, 2023 / biotechnology company creative medical technology holdings, inc. (nasdaq:celz) seems to be witnessing success in the allogeneic cell therapy market. in q4 2022, the company - best known for its regenerative approach to immunotherapy, endocrinology, urology, gynecology and orthopedics - made a significant announcement regarding the successful development of an allogeneic cell line known as allostem™.
CELZ Ratings Summary
CELZ Quant Ranking